{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:10:42Z","timestamp":1791443442937,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T00:00:00Z","timestamp":1288656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s11940-010-0100-y","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T11:29:47Z","timestamp":1288697387000},"page":"109-117","source":"Crossref","is-referenced-by-count":113,"title":["Leber\u2019s Hereditary Optic Neuropathy"],"prefix":"10.1007","volume":"13","author":[{"given":"Alfredo A.","family":"Sadun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara La","family":"Morgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,2]]},"reference":[{"key":"100_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","volume":"23","author":"V Carelli","year":"2004","unstructured":"Carelli V, Ross-Cisneros FN, Sadun AA: Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 2004, 23:53\u201389.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"100_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","volume":"55","author":"JA Fraser","year":"2010","unstructured":"Fraser JA, Biousse V, Newman NJ: The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol 2010, 55(4):299\u2013334.","journal-title":"Surv Ophthalmol"},{"key":"100_CR3","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.3201231","volume":"242","author":"DC Wallace","year":"1988","unstructured":"Wallace DC, Singh G, Lott MT, et al.: Mitochondrial DNA mutation associated with Leber\u2019s hereditary optic neuropathy. Science 1988, 242:1427\u20131430.","journal-title":"Science"},{"key":"100_CR4","first-page":"169","volume":"100","author":"AA Sadun","year":"2002","unstructured":"Sadun AA, Carelli V, Salomao SR, et al.: A very large Brazilian pedigree with 11778 Leber\u2019s hereditary optic neuropathy. Trans Am Ophthalmol Soc 2002, 100:169\u2013178. discussion 178\u2013179.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"100_CR5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0002-9394(03)00099-0","volume":"136","author":"AA Sadun","year":"2003","unstructured":"Sadun AA, Carelli V, Salomao SR, et al.: Extensive investigation of a large Brazilian pedigree of 11778\/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol 2003, 136:231\u2013238.","journal-title":"Am J Ophthalmol"},{"key":"100_CR6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/501236","volume":"78","author":"V Carelli","year":"2006","unstructured":"Carelli V, Achilli A, Valentino ML, et al.: Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am J Hum Genet 2006, 78:564\u2013574.","journal-title":"Am J Hum Genet"},{"key":"100_CR7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/519394","volume":"81","author":"G Hudson","year":"2007","unstructured":"Hudson G, Carelli V, Spruijt L, et al.: Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet 2007, 81:228\u2013233.","journal-title":"Am J Hum Genet"},{"key":"100_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/13816810701867607","volume":"29","author":"SP Shankar","year":"2008","unstructured":"Shankar SP, Fingert JH, Carelli V, et al.: Evidence for a novel x-linked modifier locus for Leber hereditary optic neuropathy. Ophthalmic Genet 2008, 29:17\u201324.","journal-title":"Ophthalmic Genet"},{"key":"100_CR9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ophtha.2004.09.033","volume":"112","author":"G Savini","year":"2005","unstructured":"Savini G, Barboni P, Valentino ML, et al.: Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber\u2019s hereditary optic neuropathy mutations. Ophthalmology 2005, 112:127\u2013131.","journal-title":"Ophthalmology"},{"key":"100_CR10","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1167\/iovs.05-0455","volume":"46","author":"DF Ventura","year":"2005","unstructured":"Ventura DF, Quiros P, Carelli V, et al.: Chromatic and luminance contrast sensitivities in asymptomatic carriers from a large Brazilian pedigree of 11778 Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2005, 46:4809\u20134814.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"100_CR11","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1167\/iovs.06-0331","volume":"48","author":"DF Ventura","year":"2007","unstructured":"Ventura DF, Gualtieri M, Oliveira AG, et al.: Male prevalence of acquired color vision defects in asymptomatic carriers of Leber\u2019s hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2007, 48:2362\u20132370.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"100_CR12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0952523808080747","volume":"25","author":"M Gualtieri","year":"2008","unstructured":"Gualtieri M, Bandeira M, Hamer RD, et al.: Psychophysical analysis of contrast processing segregated into magnocellular and parvocellular systems in asymptomatic carriers of 11778 Leber\u2019s hereditary optic neuropathy. Vis Neurosci 2008, 25:469\u2013474.","journal-title":"Vis Neurosci"},{"key":"100_CR13","first-page":"223","volume":"98","author":"AA Sadun","year":"2000","unstructured":"Sadun AA, Win PH, Ross-Cisneros FN, et al.: Leber\u2019s hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc 2000, 98:223\u2013232. discussion 232\u2013235.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"3","key":"100_CR14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ophtha.2009.07.026","volume":"117","author":"P Barboni","year":"2010","unstructured":"Barboni P, Carbonelli M, Savini G, et al.: Natural history of Leber\u2019s hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology 2010, 117(3):623\u2013627.","journal-title":"Ophthalmology"},{"key":"100_CR15","first-page":"51","volume":"104","author":"AA Sadun","year":"2006","unstructured":"Sadun AA, Salomao SR, Berezovsky A, et al.: Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study. Trans Am Ophthalmol Soc 2006, 104:51\u201361.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"100_CR16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ophtha.2004.06.034","volume":"112","author":"P Barboni","year":"2005","unstructured":"Barboni P, Savini G, Valentino ML, et al.: Retinal nerve fiber layer evaluation by optical coherence tomography in Leber\u2019s hereditary optic neuropathy. Ophthalmology 2005, 112:120\u2013126.","journal-title":"Ophthalmology"},{"key":"100_CR17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ajo.2003.08.010","volume":"137","author":"F Sadun","year":"2004","unstructured":"Sadun F, De Negri AM, Carelli V, et al.: Ophthalmologic findings in a large pedigree of 11778\/Haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol 2004, 137:271\u2013277.","journal-title":"Am J Ophthalmol"},{"key":"100_CR18","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/brain\/awp158","volume":"132","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Yu-Wai-Man P, Korsten A, et al.: Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009, 132:2317\u20132326.","journal-title":"Brain"},{"key":"100_CR19","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1167\/iovs.08-2695","volume":"50","author":"C Ramos","year":"2009","unstructured":"Ramos C, Bellusci C, Savini G, et al.: Association of optic disc size with development and prognosis of Leber\u2019s hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2009, 50:1666\u20131674.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"100_CR20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.wno.0000249320.27110.ab","volume":"26","author":"RN Sanchez","year":"2006","unstructured":"Sanchez RN, Smith AJ, Carelli V, et al.: Leber hereditary optic neuropathy possibly triggered by exposure to tire fire. J Neuroophthalmol 2006, 26:268\u2013272.","journal-title":"J Neuroophthalmol"},{"key":"100_CR21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s004150170103","volume":"248","author":"M Marinis De","year":"2001","unstructured":"De Marinis M: Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber\u2019s hereditary optic neuropathy mutation. J Neurol 2001, 248:818\u2013819.","journal-title":"J Neurol"},{"key":"100_CR22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s10384-005-0308-7","volume":"50","author":"A Ikeda","year":"2006","unstructured":"Ikeda A, Ikeda T, Ikeda N, et al.: Leber\u2019s hereditary optic neuropathy precipitated by ethambutol. Jpn J Ophthalmol 2006, 50:280\u2013283.","journal-title":"Jpn J Ophthalmol"},{"key":"100_CR23","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00417-006-0269-7","volume":"244","author":"JW Pott","year":"2006","unstructured":"Pott JW, Wong KH: Leber\u2019s hereditary optic neuropathy and vitamin B12 deficiency. Graefes Arch Clin Exp Ophthalmol 2006, 244:1357\u20131359.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"100_CR24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00041327-200020030-00006","volume":"20","author":"Y Mashima","year":"2000","unstructured":"Mashima Y, Kigasawa K, Wakakura M, et al.: Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J Neuroophthalmol 2000, 20:166\u2013170.","journal-title":"J Neuroophthalmol"},{"key":"100_CR25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajo.2005.03.058","volume":"140","author":"NJ Newman","year":"2005","unstructured":"Newman NJ, Biousse V, David R, et al.: Prophylaxis for second eye involvement in Leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. Am J Ophthalmol 2005, 140:407\u2013415.","journal-title":"Am J Ophthalmol"},{"issue":"Suppl 1","key":"100_CR26","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0039-6257(03)00004-3","volume":"48","author":"L Wheeler","year":"2003","unstructured":"Wheeler L, WoldeMussie E, Lai R: Role of alpha-2 agonists in neuroprotection. Surv Ophthalmol 2003, 48(Suppl 1):S47\u2013S51.","journal-title":"Surv Ophthalmol"},{"key":"100_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S0952523802191152","volume":"19","author":"RK Lai","year":"2002","unstructured":"Lai RK, Chun T, Hasson D, et al.: Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat. Vis Neurosci 2002, 19:175\u2013185.","journal-title":"Vis Neurosci"},{"key":"100_CR28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1167\/iovs.07-0880","volume":"49","author":"A Ghelli","year":"2008","unstructured":"Ghelli A, Porcelli AM, Zanna C, et al.: Protection against oxidant-induced apoptosis by exogenous glutathione in Leber hereditary optic neuropathy cybrids. Invest Ophthalmol Vis Sci 2008, 49:671\u2013676.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"100_CR29","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1002\/jnr.21773","volume":"86","author":"G Sala","year":"2008","unstructured":"Sala G, Trombin F, Beretta S, et al.: Antioxidants partially restore glutamate transport defect in Leber hereditary optic neuropathy cybrids. J Neurosci Res 2008, 86:3331\u20133337.","journal-title":"J Neurosci Res"},{"key":"100_CR30","unstructured":"Mahidol University: A randomized, double-blind, placebo-controlled trial of curcumin in Leber\u2019s hereditary optic neuropathy (LHON). In: ClinicalTrials.gov [Internet}. Bethesda, MD: National Library of Medicine (US). Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT00528151 ."},{"key":"100_CR31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00041327-200203000-00036","volume":"22","author":"CC Huang","year":"2002","unstructured":"Huang CC, Kuo HC, Chu CC, et al.: Rapid visual recovery after coenzyme q10 treatment of Leber hereditary optic neuropathy. J Neuroophthalmol 2002, 22:66.","journal-title":"J Neuroophthalmol"},{"key":"100_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1096-7192(02)00145-2","volume":"77","author":"V Geromel","year":"2002","unstructured":"Geromel V, Darin N, Chr\u00e9tien D, et al.: Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. Mol Genet Metab 2002, 77:21\u201330.","journal-title":"Mol Genet Metab"},{"key":"100_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(96)00311-5","volume":"148","author":"P Cortelli","year":"1997","unstructured":"Cortelli P, Montagna P, Pierangeli G, et al.: Clinical and brain bioenergetics improvement with idebenone in a patient with Leber\u2019s hereditary optic neuropathy: a clinical and 31P-MRS study. J Neurol Sci 1997, 148:25\u201331.","journal-title":"J Neurol Sci"},{"key":"100_CR34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-510X(98)00239-1","volume":"160","author":"V Carelli","year":"1998","unstructured":"Carelli V, Barboni P, Zacchini A, et al.: Leber\u2019s hereditary optic neuropathy (LHON) with 14484\/ND6 mutation in a North African patient. J Neurol Sci 1998, 160:183\u2013188.","journal-title":"J Neurol Sci"},{"key":"100_CR35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4321\/S0365-66912007000600012","volume":"82","author":"N Barnils","year":"2007","unstructured":"Barnils N, Mesa E, Munoz S, et al.: Response to idebenone and multivitamin therapy in Leber\u2019s hereditary optic neuropathy. Arch Soc Esp Oftalmol 2007, 82:377\u2013380.","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"Suppl","key":"100_CR36","first-page":"1440","volume":"50","author":"JG Eng","year":"2009","unstructured":"Eng JG, Aggarwal D, Sadun AA: Idebenone treatment in patients with Leber hereditary optic neuropathy [abstract]. Invest Ophthalmol Vis Sci 2009, 50(Suppl):1440.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"100_CR37","unstructured":"Chinnery P, et al.: Results of a 6-months randomized, placebo-controlled trial (RHODOS) with idebenone (Catena\u00ae) in Leber\u2019s Hereditary Optic Neuropathy (LHON) [poster WIP-3]. Presented at the 135th Annual Meeting of the American Neurological Association. San Francisco, CA; September 14, 2010."},{"key":"100_CR38","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1167\/iovs.08-3214","volume":"50","author":"J Guy","year":"2009","unstructured":"Guy J, Qi X, Koilkonda RD, et al.: Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system. Invest Ophthalmol Vis Sci 2009, 50:4205\u20134214.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"100_CR39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajhg.2008.08.013","volume":"83","author":"S Ellouze","year":"2008","unstructured":"Ellouze S, Augustin S, Bouaita A, et al.: Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction. Am J Hum Genet 2008, 83:373\u2013387.","journal-title":"Am J Hum Genet"},{"key":"100_CR40","doi-asserted-by":"crossref","unstructured":"Perales-Clemente E, Fern\u00e1ndez-Silva P, Ac\u00edn-P\u00e9rez R, et al.: Allotopic expression of mitochondrial-encoded genes in mammals: achieved goal, undemonstrated mechanism or impossible task? Nucleic Acids Res 2010 Sep 7 (Epub ahead of print).This careful study demonstrates how apparent complementation of the mitochondrial dysfunction by using the approach of allotopic expression may be due to selection of mtDNA mutation revertants.","DOI":"10.1093\/nar\/gkq769"},{"key":"100_CR41","doi-asserted-by":"crossref","unstructured":"Figueroa-Mart\u00ednez F, V\u00e1zquez-Acevedo M, Cort\u00e9s-Hern\u00e1ndez P, et al.: What limits the allotopic expression of nucleus-encoded mitochondrial genes? The case of the chimeric Cox3 and Atp6 genes. Mitochondrion 2010 Sep 18 (Epub ahead of print).","DOI":"10.1016\/j.mito.2010.09.003"},{"key":"100_CR42","doi-asserted-by":"crossref","first-page":"e11472","DOI":"10.1371\/journal.pone.0011472","volume":"5","author":"M Marella","year":"2010","unstructured":"Marella M, Seo BB, Thomas BB, et al.: Successful amelioration of mitochondrial optic neuropathy using the yeast NDI1 gene in a rat animal model. PLoS One 2010, 5:e11472.","journal-title":"PLoS One"},{"key":"100_CR43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2008.07.006","volume":"8","author":"T Wenz","year":"2008","unstructured":"Wenz T, Diaz F, Spiegelman BM, Moraes CT: Activation of the PPAR\/PGC-1\u03b1 pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 2008, 8:249\u2013256.","journal-title":"Cell Metab"},{"key":"100_CR44","doi-asserted-by":"crossref","unstructured":"Giordano C, Montopoli M, Perli E, et al.: Estrogens ameliorate mitochondrial dysfunction in Leber\u2019s hereditary optic neuropathy. Brain 2010, in press. This study demonstrated the role of estrogens in compensating for mitochondrial dysfunction in LHON and explains the reduced penetrance in females.","DOI":"10.1093\/brain\/awq276"},{"key":"100_CR45","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1074\/jbc.M807321200","volume":"284","author":"AM Porcelli","year":"2009","unstructured":"Porcelli AM, Angelin A, Ghelli A, et al.: Respiratory complex I dysfunction due to mitochondrial DNA mutations shifts the voltage threshold for opening of the permeability transition pore toward resting levels. J Biol Chem 2009, 284:2045\u20132052.","journal-title":"J Biol Chem"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0100-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-010-0100-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0100-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T21:22:43Z","timestamp":1559769763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-010-0100-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["100"],"URL":"https:\/\/doi.org\/10.1007\/s11940-010-0100-y","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,2]]}}}